目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. Model type
1.2.3. End use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Service outlook
2.2.2. Model type outlook
2.2.3. Application outlook
2.3. Competitive Insights

Chapter 3. India Preclinical CRO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. India Preclinical CRO Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Legal landscape
3.3.2.6. Environmental landscape

Chapter 4. India Preclinical CRO Market: Service Estimates & Trend Analysis
4.1. Service Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. India Preclinical CRO Market by Service Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
4.4.1. Service
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.1. Bioanalysis and DMPK studies
4.4.1.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.1.1.1. In vitro ADME
4.4.1.1.1.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.1.1.2. In-vivo PK
4.4.1.1.1.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2. Toxicology testing
4.4.1.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2.1.1. GLP
4.4.1.1.2.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2.1.2. Non-GLP
4.4.1.1.2.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.3. Compound management
4.4.1.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.3.1.1. Process R&D
4.4.1.1.3.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.3.1.2. Custom synthesis
4.4.1.1.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.3.1.3. Others
4.4.1.1.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.4. Chemistry
4.4.1.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.4.1.1. Medicinal chemistry
4.4.1.1.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.4.1.2. Computation chemistry
4.4.1.1.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.5. Safety pharmacology
4.4.1.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.6. Others
4.4.1.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Model type
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.1.1. Patient Derived Organoid (PDO) model
4.4.2.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.1.2. Patient derived xenograft model
4.4.2.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. End use
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.1.1. Biopharmaceutical companies
4.4.3.1.2. Government and academic institutes
4.4.3.1.3. Medical device companies

Chapter 5. India Preclinical CRO Market: Model Type Estimates & Trend Analysis
5.1. Model Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. India Preclinical CRO Market by Model Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
5.4.1. Patient Derived Organoid (PDO) model
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Patient derived xenograft model
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. India Preclinical CRO Market: End Use Estimates & Trend Analysis
6.1. End use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. India Preclinical CRO Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
6.4.1. Biopharmaceutical companies
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Government and academic institutes
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Medical device companies
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
7.4.1. Syngene International Limited
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Dabur Research
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. JSS Medical Research
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Jubilant Biosys Ltd.
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Sugen Life Sciences
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Eurofins Advinus
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. GVRP
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Veeda Clinical Research Limited
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Axis Clinicals
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Syneos Health
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Ethicare-cro
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Liveon Biolabs Pvt.Ltd.
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. IQVIA Inc
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
7.4.14. Bioneeds
7.4.14.1. Company overview
7.4.14.2. Financial performance
7.4.14.3. Product benchmarking
7.4.14.4. Strategic initiatives
7.4.15. TheraIndx Lifesciences Pvt. Ltd.
7.4.15.1. Company overview
7.4.15.2. Financial performance
7.4.15.3. Product benchmarking
7.4.15.4. Strategic initiatives

List of Tables
Table 1 List of abbreviations
Table 2 India preclinical CRO market, by service, 2018 - 2030 (USD Million)
Table 3 India preclinical CRO market, by model type, 2018 - 2030 (USD Million)
Table 4 India preclinical CRO market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market research approaches
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 India preclinical CRO market: market outlook
Fig. 8 India preclinical CRO competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 India preclinical CRO market driver impact
Fig. 14 India preclinical CRO market restraint impact
Fig. 15 India preclinical CRO market strategic initiatives analysis
Fig. 16 India preclinical CRO market: Service movement analysis
Fig. 17 India preclinical CRO market: Service outlook and key takeaways
Fig. 18 Bioanalysis and DMPK studies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 In vitro ADME market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 In-vivo PK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Toxicology testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 GLP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Non-GLP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Compound management market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Process R&D market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Custom synthesis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Chemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Medicinal chemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Computation chemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Safety pharmacology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 India preclinical CRO market: Model type movement analysis
Fig. 34 India preclinical CRO market: Model type outlook and key takeaways
Fig. 35 Patient Derived Organoid (PDO) model market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Patient derived xenograft model market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 India preclinical CRO market: End use movement analysis
Fig. 38 India preclinical CRO market: End use outlook and key takeaways
Fig. 39 Biopharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Government and academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Medical device companies market estimates and forecasts, 2018 - 2030 (USD Million)